<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">94427</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Russian Association of Endocrinologists clinical practice guidelinesfor diagnosis, treatment and preventive measures in congenital adrenal hyperplasia due to 21-hydroxylase deficiency patients in adulthood</article-title><trans-title-group xml:lang="ru"><trans-title>Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечебно-профилактическим мероприятиям при врожденной дисфункции коры надпочечников у пациентов во взрослом возрасте</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Melnichenko</surname><given-names>G. A</given-names></name><name xml:lang="ru"><surname>Мельниченко</surname><given-names>Галина Афанасьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>акад. РАН, д-р мед. наук, проф., дир. Института клинической эндокринологии ФГБУ «Эндокринологический научный центр» Минздрава России</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Troshina</surname><given-names>E. A</given-names></name><name xml:lang="ru"><surname>Трошина</surname><given-names>Екатерина Анатольевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. отд-ния терапии с группой ожирения ФГБУ «Эндокринологический научный центр» Минздрава России</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Molashenko</surname><given-names>N. V</given-names></name><name xml:lang="ru"><surname>Молашенко</surname><given-names>Наталья Валерьевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, вед. науч. сотр. отд-ния терапии с группой ожирения ФГБУ «Эндокринологический научный центр» Минздрава России</p></bio><email>molashenko@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sazonova</surname><given-names>A. I</given-names></name><name xml:lang="ru"><surname>Сазонова</surname><given-names>Анна Игоревна</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, врач, терапевтическое отд-ние ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Uzhegova</surname><given-names>Zh. A</given-names></name><name xml:lang="ru"><surname>Ужегова</surname><given-names>Жанна Александровна</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач отд-ния эндокринной гинекологии ФГБУ «Эндокринологический научный центр» Минздрава России</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Endocrinology research center of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Эндокринологический научный центр Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России</institution></aff></aff-alternatives><content-language>ru</content-language><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2016-04-15"><day>15</day><month>04</month><year>2016</year></pub-date><pub-date date-type="collection"><year>2016</year></pub-date><volume>18</volume><issue>4</issue><issue-title xml:lang="en">VOL 18, NO4 (2016)</issue-title><issue-title xml:lang="ru">ТОМ 18, №4 (2016)</issue-title><fpage>8</fpage><lpage>19</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><pub-history><event event-type="received"><event-desc>Received:<date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></event-desc></event><event event-type="pub"><event-desc>Published:<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2016-04-15"><day>15</day><month>04</month><year>2016</year></pub-date></event-desc></event></pub-history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/94427">https://consilium.orscience.ru/2075-1753/article/view/94427</self-uri><abstract xml:lang="en"><p>Russian clinical practice guidelines presents the main approaches to the diagnosis, treatment and follow-up of patients with classical and nonclassical forms 21-hydroxylase deficiency. The techniques of diagnostic tests and parameters of hormonal indicators to assess the adequacy of replacement therapy glucocorticoids and mineralocorticoids are considered.</p></abstract><trans-abstract xml:lang="ru"><p>В клинических рекомендациях представлены основные подходы к диагностике, лечению и динамическому наблюдению пациентов с классическими и неклассической формами дефицита 21-гидроксилазы. Рассмотрены методики проведения диагностических проб и параметры гормональных показателей для оценки адекватности заместительной терапии глюко - и минералокортикоидами.</p></trans-abstract><kwd-group xml:lang="en"><kwd>congenital adrenal hyperplasia</kwd><kwd>nonclassical congenital adrenal hyperplasia</kwd><kwd>17-OH-progesterone</kwd><kwd>Sinakten</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>врожденная дисфункция коры надпочечников</kwd><kwd>неклассическая врожденная дисфункция коры надпочечников</kwd><kwd>17-ОН-проге- стерон</kwd><kwd>Синактен</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Федеральные клинические рекомендации - протоколы по ведению пациентов с врожденной дисфункцией коры надпочечников в детском возрасте. Пробл. эндокринологии. 2014; 2: 42-50.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95 (9): 4133-60.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Speiser P.W, Dupont B, Rubinstein P et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37: 650-67.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Сазонова А.И. Соматический статус и метаболические нарушения у взрослых пациентов с различными формами врожденной дисфункции коры надпочечников. Дис. … канд. мед. наук. М., 2013.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Azziz R, Hincapie L.A, Knochenhauer E.S et al. Screening for 21-hydroxylase - deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72: 915-25.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Bidet M, Bellanné-Chantelot C, Galand-Portier M.B et al. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009; 94: 1570-8.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Török D, Halasz Z, Garami M et al. Limited value of serum steroid measurements in identification of mild form of 21-hydroxylase deficiency. Exp Clin Endocrinol Diabetes 2003; 111: 27-32.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Bidet M, Bellanné-Chantelot C, Galand-Portier M.B et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95: 1182-90.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Moran C, Azziz R, Weintrob N et al. Reproductive outcome of women with 21-hydroxylase - deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91: 3451-6.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>New M.I. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91: 4205-14.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Riepe F.G, Krone N, Viemann M et al. Management of congenital adrenal hyperplasia: results of the ESPE questionnaire. Horm Res 2002; 58: 196-205.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Brunton L.L. Goodman &amp; Gilman’s the pharmacological basis of therapeutics. McGraw Hill, 2006.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Charmandari E, Matthews D.R, Johnston A et al. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 2001; 86: 4679-85.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rosenfield R.L. Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2002; 87: 2993.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Spritzer P, Billaud L, Thalabard J.C et al. Cyproterone acetate versus hydrocortisone treatment in late - onset adrenal hyperplasia. J Clin Endocrinol Metab 1990; 70: 642-6.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Merke D.P, Bornstein S.R. Congenital adrenal hyperplasia. Lancet 2005; 365: 2125-36.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Stikkelbroeck N.M, Oyen W.J, van der Wilt G.J et al. Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003; 88: 1036-42.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Falhammar H, Filipsson H, Holmdahl G et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92: 110-6.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zimmermann A, Grigorescu-Sido P, Al-Khzouz C et al. Alterations in lipid and carbohydrate metabolism in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 2010; 74 (1): 41-9.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Bachelot A, Chakhtoura Z, Samara-Boustani D et al. Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency. Int J Pediatr Endocrinol 2010.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Barzon L, Sonino N, Fallo F et al. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 2003; 149: 273-85.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Varan A, Unal S, Ruacan S, Vidinlisan S. Adrenocortical carcinoma associated with adrenogenital syndrome in a child. Med Pediatr Oncol 2000; 35: 88-90.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hague W.M, Adams J, Rodda C et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990; 33: 501-10.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Bryan S.M, Honour J.W, Hindmarsh P.C. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. J Clin Endocrinol Metab 2009.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Merza Z, Rostami-Hodjegan A, Memmott A, Doane A. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2006; 65: 45-50.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Verma S, Sinaii N, Kim M.S et al. A pharmacokinetic and pharmacodynamic study of delayed - and extended release hydrocortisone (ChronocortTM) versus conventional hydrocortisone (CortefTM) in the treatment of congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2010; 72: 441-7.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Cabrera M.S, Vogiatzi M.G, New M.I. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 3070-8.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Claahsen - van der Grinten H.L, Otten B.J, Hermus A.R et al. Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage. Fertil Steril 2008; 89: 597-601.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Charmandari E, Brook C.G, Hindmarsh P.C. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Arch Dis Child 2002; 86: 266-9.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Hagenfeldt K, Janson P.O, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23: 1607-13.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Файзулин А.К., Батыгин М.П., Глыбина Т.М., Шкитырь З.В. Современные методы хирургической коррекции пороков наружных гениталий у девочек с врожденной дисфункцией коры надпочечников. Андрология и генитальная хирургия. 2011; 3: 69-73.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Casteras A, De Silva P, Rumsby G, Conway G.S. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70: 833-7.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Lo J.C, Schwitzgebel V.M, Tyrrell J.B et al. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1999; 84: 930-6.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Hughes I.A, Houk C, Ahmed S.F, Lee P.A. Consensus statement on management of intersex disorders. Arch Dis Child 2006; 91: 554-63.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Dessens A.B, Slijper F.M, Drop S.L. Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 2005; 34: 389-97.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Meyer-Bahlburg H.F, Dolezal C, Baker S.W, New M.I. Sexual orientation in women with classical or non - classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav 2008; 37: 85-99.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Зубкова Н.А., Дворянчиков Н.В., Окулов А.Б., Касаткина Э.П. Психосексуальный статус больных с врожденной дисфункцией коры надпочечников. Успехи теоретической и клинической медицины: материалы научных исследований РМАПО. М., 2003; с. 228-9.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Meyer-Bahlburg H.F. Health - related quality of life in intersexuality. Acta Paediatr Suppl 1999; 88: 114-5.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Martin K.A, Chang R.J, Ehrmann D.A et al. Evaluation and Treatment Of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93 (Issue 4): 1105-20.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Андреева Е.Н., Ужегова Ж.А. Врожденная дисфункция коры надпочечников (адреногенитальный синдром): скрининг, диагностика, лечение. Методические рекомендации. М., 2010.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Дедов И.И., Краснопольский В.И., Сухих Г.Т. Российский национальный консенсус «Гестационный сахарный диабет: диагностика, лечение, послеродовое наблюдение». Сахарный диабет. 2012; 4: 4-10.</mixed-citation></ref></ref-list></back></article>
